Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study
Thorsten Kuehn(Klinikum Esslingen), Marc Thill(Agaplesion Markus Hospital), Rosa Di Micco, Lia Pamela Rebaza(EsSALUD), Oreste Gentilini(San Raffaele University of Rome), Andraž Perhavec(The University of Texas MD Anderson Cancer Center), Michalis Kontos(National and Kapodistrian University of Athens), Ashutosh Kothari(Guy's and St Thomas' NHS Foundation Trust), Geeta Kadayaprath(Max Healthcare), Marian Vanhoeij(Universitair Ziekenhuis Brussel), Elmar Stickeler(Universitätsklinikum Aachen), Hans‐Christian Kolberg, Helidon Nina(Mother Teresa Hospital), Bilge Aktas Sezen(Klinikum Esslingen), Douglas Zippel(Sheba Medical Center), Tomasz Berger(Rems-Murr-Klinikum), Nina Ditsch(Ludwig-Maximilians-Universität München), Laura Niinikoski(University of Helsinki), Güldeniz Karadeniz Çakmak(Zonguldak Bülent Ecevit University), Mauro Porpiglia(Ospedale Sant'Anna), Isabel T. Rubio(Clinica Universidad de Navarra), David Pinto(Champalimaud Foundation), Michael Hauptmann(Medizinische Hochschule Brandenburg Theodor Fontane), Eduard-Alexandru Bonci(Iuliu Hațieganu University of Medicine and Pharmacy), Maria Luisa Gasparri(Ospedale regionale di Lugano), Jana de Boniface(Karolinska Institutet), Toralf Reimer(University of Rostock), Michael P. Lux(Brüderkrankenhaus St. Josef Paderborn), Steffi Hartmann(University of Rostock), Kristina Wihlfahrt(Schmerzklinik Kiel), Sarun Thongvitokomarn(King Chulalongkorn Memorial Hospital), Meryem Günay Gürleyik(Haydarpaşa Numune Eğitim ve Araştırma Hastanesi), Dawid Murawa(University of Zielona Góra), Franziska Ruf(University Hospital Schleswig-Holstein), Florentia Peintinger(Medical University of Graz), Maggie Banys‐Paluchowski(University Hospital Schleswig-Holstein), Lukáš Dostálek(Charles University), Jennifer Schroth(Medizinische Hochschule Brandenburg Theodor Fontane), Sarah Fröhlich(University of Rostock), Tsvetomir Ivanov(Hyogo Brain and Heart Center), Timo Basali(Klinikum Esslingen), Markus Hahn, Esther Schmidt(European Bioinformatics Institute), Ellen Schlichting(Oslo University Hospital), Dirk Watermann(Evangelisches Diakoniekrankenhaus), Annette Lebeau(Universität Hamburg), Katharina Jursik(Klinikum Esslingen), A Rief(Medical University of Graz), Hagigat Valiyeva Qanimat(Azerbaijan Medical University)
Cited by 5
Related Papers
Patterns of somatic mutation in human cancer genomes
|Nature|2007|3.1k
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|2.2k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition
|Cancer Discovery|2012|622
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|544